Oragenics, Inc. (OGEN) Financials

OGEN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 5.5 million 1.8 million
March 31, 2026 7.5 million 1.3 million
Dec. 31, 2025 10.1 million 1.8 million
Sept. 30, 2025 12.7 million 2.9 million

OGEN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -2.2 million 34969
March 31, 2026 -2.2 million 17386
Dec. 31, 2025 -2.8 million 642.2 million
Sept. 30, 2025 -3.0 million 92510

OGEN Net Income

No data available :(

OGEN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 3.9 million - -
March 31, 2026 6.1 million - -
Dec. 31, 2025 8.4 million - -
Sept. 30, 2025 11.4 million - -

OGEN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 4.4 million
March 31, 2026 4.3 million
Dec. 31, 2025 4.3 million
Sept. 30, 2025 15609

OGEN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 4 1.2 million 1.4 million -
March 31, 2026 4 645470 1.6 million -
Dec. 31, 2025 2 670543 1.8 million -
Sept. 30, 2025 5 930894 2.2 million -

OGEN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - -
Dec. 31, 2025 - -
Sept. 30, 2025 - -

OGEN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

OGEN

Price: $0.55

52 week price:
0.48
1.45

Earnings Per Share: -1.43 USD

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 23200

Market Capitalization: 2.4 million

Links: